Researchers at the National Institutes of Health (NIH) have developed eye drops that extend vision in animal models of a ...

It occurs when the aging process inflicts damage on the macula, the central part of the retina of human eye, responsible for clear and sharp sight. Am I at risk of getting AMD? There are various ...

As February is AMD Awareness Month, Optegra Eye Clinic Preston is spotlighting ... people with Dry AMD which is non-invasive, with no drops, no injections. This first-ever active treatment for ...

In the randomized, sham-controlled ARTEMIS study, patients will receive either a dose of ixo-vec or a standard care regimen of anti-VEGF Eylea.

Adverum Biotechnologies (ADVM) announced the initiation of the ARTEMIS Phase 3 study. This pivotal trial is designed to evaluate the efficacy ...

However, the decline in Advanced Micro Devices (NASDAQ: AMD) stock started one year ago ... which represented eye-popping growth of 94%. However, that was a mere fraction of the $115.1 billion ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and improve vision outcomes for patients with wet AMDARTEMIS ...